Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Bevacizumab Biosimilar market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bevacizumab Biosimilarmarket, defines the market attractiveness level of Bevacizumab Biosimilar market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bevacizumab Biosimilar industry, describes the types of Bevacizumab Biosimilar market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bevacizumab Biosimilar market and the development prospects and opportunities of Bevacizumab Biosimilar industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bevacizumab Biosimilar market in Chapter 13.
By Player:
Reliance lifesciences
Pfizer
Biocon
Hetero Drugs
Amgen
Bevacizumab
Fujifilm Kyowa Kirin Biologics
Celgene Corporation
Allergan
Beaconpharma
By Type:
100mg
400mg
By End-User:
Colorectal Cancer
Lung Cancer
Breast Cancer
Renal Cancer
Brain Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bevacizumab Biosimilar Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bevacizumab Biosimilar Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bevacizumab Biosimilar Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bevacizumab Biosimilar Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bevacizumab Biosimilar Market Analysis and Outlook to 2022
-
7.1 Global Bevacizumab Biosimilar Consumption (2017-2022)
-
7.2 United States Bevacizumab Biosimilar Consumption (2017-2022)
-
7.3 Europe Bevacizumab Biosimilar Consumption (2017-2022)
-
7.4 China Bevacizumab Biosimilar Consumption (2017-2022)
-
7.5 Japan Bevacizumab Biosimilar Consumption (2017-2022)
-
7.6 India Bevacizumab Biosimilar Consumption (2017-2022)
-
7.7 South Korea Bevacizumab Biosimilar Consumption (2017-2022)
8 Region and Country-wise Bevacizumab Biosimilar Market Analysis and Outlook to 2028
-
8.1 Global Bevacizumab Biosimilar Consumption Forecast (2022-2028)
-
8.2 United States Bevacizumab Biosimilar Consumption Forecast (2022-2028)
-
8.3 Europe Bevacizumab Biosimilar Consumption Forecast (2022-2028)
-
8.4 China Bevacizumab Biosimilar Consumption Forecast (2022-2028)
-
8.5 Japan Bevacizumab Biosimilar Consumption Forecast (2022-2028)
-
8.6 India Bevacizumab Biosimilar Consumption Forecast (2022-2028)
-
8.7 South Korea Bevacizumab Biosimilar Consumption Forecast (2022-2028)
9 Global Bevacizumab Biosimilar Market Outlook by Types and Applications to 2022
-
9.1 Global Bevacizumab Biosimilar Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 400mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Bevacizumab Biosimilar Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Renal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Consumption and Growth Rate (2017-2022)
10 Global Bevacizumab Biosimilar Market Outlook by Types and Applications to 2028
-
10.1 Global Bevacizumab Biosimilar Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 400mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bevacizumab Biosimilar Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Renal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Bevacizumab Biosimilar Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bevacizumab Biosimilar Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bevacizumab Biosimilar Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bevacizumab Biosimilar Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bevacizumab Biosimilar Market Competitive Analysis
-
14.1 Reliance lifesciences
-
14.1.1 Reliance lifesciences Company Details
-
14.1.2 Reliance lifesciences Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Reliance lifesciences Bevacizumab Biosimilar Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Bevacizumab Biosimilar Product and Service
-
14.3 Biocon
-
14.3.1 Biocon Company Details
-
14.3.2 Biocon Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biocon Bevacizumab Biosimilar Product and Service
-
14.4 Hetero Drugs
-
14.4.1 Hetero Drugs Company Details
-
14.4.2 Hetero Drugs Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hetero Drugs Bevacizumab Biosimilar Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Bevacizumab Biosimilar Product and Service
-
14.6 Bevacizumab
-
14.6.1 Bevacizumab Company Details
-
14.6.2 Bevacizumab Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bevacizumab Bevacizumab Biosimilar Product and Service
-
14.7 Fujifilm Kyowa Kirin Biologics
-
14.7.1 Fujifilm Kyowa Kirin Biologics Company Details
-
14.7.2 Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Product and Service
-
14.8 Celgene Corporation
-
14.8.1 Celgene Corporation Company Details
-
14.8.2 Celgene Corporation Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Celgene Corporation Bevacizumab Biosimilar Product and Service
-
14.9 Allergan
-
14.9.1 Allergan Company Details
-
14.9.2 Allergan Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Allergan Bevacizumab Biosimilar Product and Service
-
14.10 Beaconpharma
-
14.10.1 Beaconpharma Company Details
-
14.10.2 Beaconpharma Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Beaconpharma Bevacizumab Biosimilar Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bevacizumab Biosimilar
-
Figure Bevacizumab Biosimilar Picture
-
Table Global Bevacizumab Biosimilar Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bevacizumab Biosimilar Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bevacizumab Biosimilar Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bevacizumab Biosimilar Consumption by Country (2017-2022)
-
Figure United States Bevacizumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Table Europe Bevacizumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure China Bevacizumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Japan Bevacizumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure India Bevacizumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bevacizumab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global Bevacizumab Biosimilar Consumption Forecast by Country (2022-2028)
-
Figure United States Bevacizumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bevacizumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bevacizumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bevacizumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bevacizumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bevacizumab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg Consumption and Growth Rate (2017-2022)
-
Figure Global 400mg Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bevacizumab Biosimilar Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bevacizumab Biosimilar Export by Region (Top 5 Countries) (2017-2028)
-
Table Reliance lifesciences (Foundation Year, Company Profile and etc.)
-
Table Reliance lifesciences Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reliance lifesciences Bevacizumab Biosimilar Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bevacizumab Biosimilar Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Bevacizumab Biosimilar Product and Service
-
Table Hetero Drugs (Foundation Year, Company Profile and etc.)
-
Table Hetero Drugs Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Drugs Bevacizumab Biosimilar Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Bevacizumab Biosimilar Product and Service
-
Table Bevacizumab (Foundation Year, Company Profile and etc.)
-
Table Bevacizumab Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bevacizumab Bevacizumab Biosimilar Product and Service
-
Table Fujifilm Kyowa Kirin Biologics (Foundation Year, Company Profile and etc.)
-
Table Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Bevacizumab Biosimilar Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Bevacizumab Biosimilar Product and Service
-
Table Beaconpharma (Foundation Year, Company Profile and etc.)
-
Table Beaconpharma Bevacizumab Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beaconpharma Bevacizumab Biosimilar Product and Service
-
